Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theralase Technologies Inc. V.TLT.W


Primary Symbol: V.TLT Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

View:
Post by rhodiumd on Apr 11, 2024 3:23pm

Level II

Number of orders Total size Table showing latest bid details for TLT
1 500 0.175
1 5000 0.17
4 21000 0.165
7 55500 0.16
7 15500 0.155
12 65000 0.15
3 10500 0.145
3 37500 0.14
1 2500 0.135
1 2500 0.13
Ask Table
Table showing latest ask details for TLT Total size Number of orders
0.18 206500 4
0.185 11500 2
0.19 3000 2
0.195 17000 3
0.20 57000 4
0.205 2000 1
0.21 78000 5
0.215 22000 2
0.22 32000 6
0.225 52000 3
Comment by Legit62 on Apr 11, 2024 3:52pm
someone trying to make profit before next PP
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities